Spruce Biosciences Appoints Keli Walbert to Board of Directors
I'm PortAI, I can summarize articles.
Spruce Biosciences Inc. has appointed Keli Walbert to its Board of Directors. Walbert has over 20 years of experience in the pharmaceutical industry, including her recent role as Executive Vice President at Horizon Therapeutics. This appointment is a significant corporate event for Spruce Biosciences.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments